The global liver disease diagnostics market size is expected to reach USD 50.61 billion by 2028 according to a new study by Polaris Market Research. The report “Liver Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Diagnosis Technique (Imaging, Laboratory Tests, Endoscopy, Biopsy, Others); By End-Use (Hospitals, Laboratories, Others), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Asia Pacific market for liver disease diagnostics is projected to witness lucrative growth over the assessment period. The rising geriatric population, increase in incidences rate of liver-related disorders, owing to rise in alcohol consumption, and awareness among individuals about regular checkups is contributing to the region’s market growth for liver disease diagnostics.
Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/liver-disease-diagnostics-market/request-for-sample
Moreover, a positive regulatory scenario towards advanced technologies with integrated imaging services also favored the market growth for liver disease diagnostics. In this direction, in August 2018, LiverMultiScan, an Australia-based company, received clearance to diagnose patients in Australia suffering from NAFLD and NASH diseases.
As per the market statistics published by the United Nations, through its World Population Prospects working group, in 2019, by 2050, there would be 1 in 6 old age people (over 65 years), as compared to 1 in 11 in 2019. This old age group accounts for one-fifth of the total population in 17 countries, and it is projected to be increased by the end of this century in 155 countries, covering 61 percent of the global population. This is mainly due to an increase in life expectancy and declining fertility rates among the people.
Market participants such as Horiba Medical, Abbott, Fujifilm Corporation, Roche Ltd, Randox Laboratories Ltd., Boston Scientific Corporation, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, and Siemens Healthcare GmbH. are some of the key players operating in the market for liver disease diagnostics.
Key players in the market for liver disease diagnostics are undertaking initiatives to favor non-profit organizations to spread awareness and help patients in the diagnosis of liver abnormalities. In this direction, in January 2020, Echosens supported the U.S.-based academic institution Fatty Liver Foundation (FLF) through FibroScan to enable physicians in the diagnostics of liver-related diseases and disorders.
Complete Summary with TOC Available @ https://www.polarismarketresearch.com/industry-analysis/liver-disease-diagnostics-market/toc
Polaris Market research has segmented the liver disease diagnostics market report on the basis of diagnosis technique, type, and region:
Liver Disease Diagnostics, Diagnosis Technique Outlook (Revenue – USD Million, 2016 – 2028)
- Imaging
- Laboratory tests
- Endoscopy
- Biopsy
- Others
Liver Disease Diagnostics, End-Use Outlook (Revenue – USD Million, 2016 – 2028)
- Hospitals
- Laboratories
- Others
Liver Disease Diagnostics, Regional Outlook (Revenue – USD Million, 2016 – 2028)
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Spain
- Netherlands
- Austria
- Asia Pacific
- China
- India
- Japan
- Malaysia
- South Korea
- Indonesia
- Central & South America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Avail discount on this report @ https://www.polarismarketresearch.com/industry-analysis/liver-disease-diagnostics-market/request-for-discount-pricing
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world.
Contact us-
Polaris Market Research
Phone: 1-646-568-9980
Email: [email protected]
Web: www.polarismarketresearch.com
The global COVID-19 sample collection kits market size is expected to reach USD 16.56 billion by 2028 according to a new study by Polaris Market Research.
The report “COVID-19 Sample Collection Kits Market Share, Size, Trends, Industry Analysis Report, By Product (Swabs, Viral Transport Media, Blood Collection Kits, Others); By Application (Diagnostics, Research); By Collection Site (Hospitals & Clinics, Home Test), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
As per CDC, samples could also be collected from the respiratory tract, when the use of nasopharyngeal swabs is not sufficient.
In line with this, in November 2020, Puritan has received funding of more than USD 11.6 million for the expansion of swab production to cater to the demand of around 3 million swabs in a month.
COVID-19 sample collection kits industry participants such as Lucence Diagnostics Pte Ltd., Laboratory Corporation of America Holdings, Trinity Biotech, Puritan Medical Products, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., COPAN Diagnostics, Hardy Diagnostics, Quidel Corporation, Quest Diagnostics, Vitagene Inc., HiMedia Laboratories, and VIRCELL S.L.
Players and organizations across the globe are developing innovative products for sample collection.
